These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 1360062)

  • 1. Apolipoprotein epsilon 4 and coronary artery disease.
    de Knijff P; Jansen H; Lie KI; Havekes LM
    Lancet; 1992 Nov; 340(8831):1351. PubMed ID: 1360062
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoprotein epsilon 4 and coronary artery disease.
    Payne MN; Green E; Walker MR; Beattie JM; Murray RG; Jones AF
    Lancet; 1992 Nov; 340(8831):1350. PubMed ID: 1360057
    [No Abstract]   [Full Text] [Related]  

  • 3. Apolipoprotein E-epsilon 4 frequency in geriatric depression.
    Krishnan KR; Tupler LA; Ritchie JC; McDonald WM; Knight DL; Nemeroff CB; Carroll BJ
    Biol Psychiatry; 1996 Jul; 40(1):69-71. PubMed ID: 8780857
    [No Abstract]   [Full Text] [Related]  

  • 4. Apolipoprotein epsilon 4 is not a genetic risk factor for coronary artery disease or restenosis after percutaneous transluminal coronary angioplasty.
    Damaraju S; Yu QT; Safavi F; Marian AJ
    Am J Cardiol; 1995 Jun; 75(16):1181-3. PubMed ID: 7762511
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between severity of coronary artery disease and apolipoprotein E gene polymorphism.
    Arslan Ince FD; Atay A; Köseoğlu M; Yeşil M; Deveci E
    Anadolu Kardiyol Derg; 2010 Jun; 10(3):202-8. PubMed ID: 20538553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E gene polymorphism and gender.
    Kolovou G; Damaskos D; Anagnostopoulou K; Cokkinos DV
    Ann Clin Lab Sci; 2009; 39(2):120-33. PubMed ID: 19429797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E gene promoter (-219G/T) polymorphism is associated with premature coronary heart disease.
    Viitanen L; Pihlajamäki J; Miettinen R; Kärkkäinen P; Vauhkonen I; Halonen P; Kareinen A; Lehto S; Laakso M
    J Mol Med (Berl); 2001 Dec; 79(12):732-7. PubMed ID: 11862316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world.
    Gerdes LU; Klausen IC; Sihm I; Faergeman O
    Genet Epidemiol; 1992; 9(3):155-67. PubMed ID: 1381696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of apolipoprotein E gene plasma levels of lipids, lipoproteins, apolipoproteins and its relation with coronary heart disease].
    Zhu T; Wang Z; Zhao S
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):149-51. PubMed ID: 10681829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Connections between apolipoprotein E genotypes and the development of cardiovascular diseases].
    Végh C; Langmár Z; Szerző M; Agota A; Marosi K; Szabolcs Z; Nagy ZB
    Orv Hetil; 2012 Dec; 153(52):2070-6. PubMed ID: 23261995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians.
    Davignon J; Bouthillier D; Nestruck AC; Sing CF
    Trans Am Clin Climatol Assoc; 1988; 99():100-10. PubMed ID: 3503432
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of polymorphisms for apolipoprotein B (ins/del, XbaI, EcoRI) and apolipoprotein E on serum lipids and apolipoproteins in a Javanese population.
    Gajra B; Candlish JK; Saha N; Heng CK; Soemantri AG; Tay JS
    Genet Epidemiol; 1994; 11(1):19-27. PubMed ID: 8013886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P; Mensink RP; Hornstra G
    Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk.
    Wang C; Zhou X; Ye S; Han D; Tan X; Zheng F; Shi Q
    Int J Hyg Environ Health; 2006 May; 209(3):265-73. PubMed ID: 16459141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis.
    Wilson PW; Schaefer EJ; Larson MG; Ordovas JM
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1250-5. PubMed ID: 8857921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.
    Kimura H; Suzuki Y; Gejyo F; Karasawa R; Miyazaki R; Suzuki S; Arakawa M
    Am J Kidney Dis; 1998 Apr; 31(4):666-73. PubMed ID: 9531184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease.
    Petrovic D; Zorc M; Peterlin B
    Folia Biol (Praha); 2000; 46(5):181-5. PubMed ID: 11055796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
    Duman BS; Oztürk M; Yilmazer S; Hatemi H
    Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E-epsilon 4 allele doses in late-onset Alzheimer's disease.
    Lucotte G; Turpin JC; Landais P
    Ann Neurol; 1994 Oct; 36(4):681-2. PubMed ID: 7944308
    [No Abstract]   [Full Text] [Related]  

  • 20. Apolipoprotein E genotype and psychosis.
    Igata-Yi R; Igata T; Ishizuka K; Kimura T; Sakamoto S; Katsuragi S; Takamatsu J; Miyakawa T
    Biol Psychiatry; 1997 Apr; 41(8):906-8. PubMed ID: 9099418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.